Atria Investments’s Cerence CRNC Stock Holding History

Atria Investments’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,099	Closed	-$1.08M	–	791
2021 Q2	$1.08M	Buy	+10,099	New	+$994K	0.02%	731

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Atria Investments's CRNC Position: Q3 2021 in Review

Atria Investments sold out of Cerence (CRNC) in Q3 2021, closing a stake of 10,099 shares — an estimated $1.08M sold.

Atria Investments first reported a position in CRNC in Q2 2021 and held it in 1 quarter. The position peaked at $1.08M in Q2 2021. 362 funds tracked by Wall St. Rank hold CRNC as of Q3 2021.

Atria Investments reported no remaining Cerence position as of Q3 2021 after selling out during the quarter.
Atria Investments sold 10,099 Cerence shares in Q3 2021, an estimated $1.08M.
Atria Investments first reported a position in Cerence in Q2 2021 and held it in 1 quarter.
Atria Investments's Cerence position peaked at $1.08M in Q2 2021.
362 funds tracked by Wall St. Rank held Cerence as of Q3 2021.

Based on Atria Investments's 13F filing for Q3 2021, filed 16 Nov 2021.